About schedules
• Please note that all schedules might be subject to changes. Therefore, it is always best to subscribe, or to bookmark them in your web browser. Do not download schedules as pdf or ics files.
• If your schedule seems to be incorrect or is missing altogether, please get in touch with a course administrator at your department.
About exam seat allocation
• You will find your assigned seat by clicking on the link under the column "Allocated seat (exam)". The link is also found in the calendar subscription. This applies to written exams co-ordinated by the University's Examination Services.
• If no link is shown in the schedule, the exam is been co-ordinated by your department. Contact a course administrator should you need further information.
• NOTE: Seats are allocated (and made visible through the link) only a few days (generally two days) prior to the exam.
September
18
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 6, Maxime Gestin, Lab 4: Receptor binding part 1
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 6, Maxime Gestin, Lab 4: Receptor binding part 1
10:30
09:30
20
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 1, Maxime Gestin, Lab 4: Receptor binding part 1
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 1, Maxime Gestin, Lab 4: Receptor binding part 1
10:30
09:30
26
KÖL-K434, Arrhenius KÖL, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 4, Maxime Gestin, Lab 4: Receptor binding part 1
KÖL-K434, Arrhenius KÖL, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 4, Maxime Gestin, Lab 4: Receptor binding part 1
17:00
09:30
18
KÖL-K434, Arrhenius KÖL, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 6, Maxime Gestin, Lab 4: Receptor binding part 1
KÖL-K434, Arrhenius KÖL, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 6, Maxime Gestin, Lab 4: Receptor binding part 1
17:00
10:30
20
KÖL-K434, Arrhenius KÖL, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 1, Maxime Gestin, Lab 4: Receptor binding part 1
KÖL-K434, Arrhenius KÖL, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 1, Maxime Gestin, Lab 4: Receptor binding part 1
17:00
10:30
6
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 1, Anna-Lena Ström, Lab 2: Brain anatomy
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 1, Anna-Lena Ström, Lab 2: Brain anatomy
17:00
13:00
7
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 2, Anna-Lena Ström, Lab 2: Brain anatomy
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 2, Anna-Lena Ström, Lab 2: Brain anatomy
17:00
13:00
10
C472, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 2, Anders Undén, Lab 5: Neurosim
C472, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 2, Anders Undén, Lab 5: Neurosim
17:00
13:00
10
C472, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 1, Anders Undén, Lab 5: Neurosim
C472, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 1, Anders Undén, Lab 5: Neurosim
17:00
13:00
10
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 5, Anna-Lena Ström, Lab 2: Brain anatomy
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 5, Anna-Lena Ström, Lab 2: Brain anatomy
17:00
13:00
11
C472, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 4, Anders Undén, Lab 5: Neurosim
C472, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 4, Anders Undén, Lab 5: Neurosim
17:00
13:00
11
C472, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 3, Anders Undén, Lab 5: Neurosim
C472, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 3, Anders Undén, Lab 5: Neurosim
17:00
13:00
11
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 6, Anna-Lena Ström, Lab 2: Brain anatomy
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 6, Anna-Lena Ström, Lab 2: Brain anatomy
17:00
13:00
12
C472, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 5, Anders Undén, Lab 5: Neurosim
C472, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 5, Anders Undén, Lab 5: Neurosim
17:00
13:00
12
C472, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 6, Anders Undén, Lab 5: Neurosim
C472, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 6, Anders Undén, Lab 5: Neurosim
17:00
13:00
12
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 3, Anna-Lena Ström, Lab 2: Brain anatomy
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 3, Anna-Lena Ström, Lab 2: Brain anatomy
17:00
13:00
13
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 4, Anna-Lena Ström, Lab 2: Brain anatomy
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 4, Anna-Lena Ström, Lab 2: Brain anatomy
17:00
13:00
17
KÖL-K434, Arrhenius KÖL, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 2, Daniel Patrick Twohig, Lab 1: Ca2+ flux part 1
KÖL-K434, Arrhenius KÖL, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 2, Daniel Patrick Twohig, Lab 1: Ca2+ flux part 1
17:00
13:00
18
KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 2, Daniel Patrick Twohig, Lab 1: Ca2+ flux part 2
KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 2, Daniel Patrick Twohig, Lab 1: Ca2+ flux part 2
17:00
13:00
19
C472, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 6, Maxime Gestin, Lab 4: Receptor binding part 2
C472, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 6, Maxime Gestin, Lab 4: Receptor binding part 2
17:00
13:00
20
KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 3, Daniel Patrick Twohig, Lab 1: Ca2+ flux part 1. In K434
KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 3, Daniel Patrick Twohig, Lab 1: Ca2+ flux part 1. In K434
17:00
13:00
21
C472, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 1, Maxime Gestin, Lab 4: Receptor binding part 2
C472, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 1, Maxime Gestin, Lab 4: Receptor binding part 2
17:00
13:00
21
KÖL-K434, Arrhenius KÖL, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 3, Daniel Patrick Twohig, Lab 1: Ca2+ flux part 2
KÖL-K434, Arrhenius KÖL, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 3, Daniel Patrick Twohig, Lab 1: Ca2+ flux part 2
17:00
13:00
24
KÖL-K434, Arrhenius KÖL, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 6, Daniel Patrick Twohig, Lab 1: Ca2+ flux part 1
KÖL-K434, Arrhenius KÖL, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 6, Daniel Patrick Twohig, Lab 1: Ca2+ flux part 1
17:00
13:00
25
KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 6, Daniel Patrick Twohig, Lab 1: Ca2+ flux part 2
KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 6, Daniel Patrick Twohig, Lab 1: Ca2+ flux part 2
17:00
13:00
27
KÖL-K434, Arrhenius KÖL, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 5, Daniel Patrick Twohig, Lab 1: Ca2+ flux part 1
KÖL-K434, Arrhenius KÖL, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 5, Daniel Patrick Twohig, Lab 1: Ca2+ flux part 1
17:00
13:00
27
C472, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 4, Maxime Gestin, Lab 4: Receptor binding part 2
C472, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 4, Maxime Gestin, Lab 4: Receptor binding part 2
17:00
13:00
28
KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 5, Daniel Patrick Twohig, Lab 1: Ca2+ flux part 2
KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 5, Daniel Patrick Twohig, Lab 1: Ca2+ flux part 2
17:00
13:00
October
18
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Seminar, Presentation, Group 2, Anders Undén, Literature seminars
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Seminar, Presentation, Group 2, Anders Undén, Literature seminars
12:00
09:00
18
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Seminar, Presentation, Group 1, Anders Undén, Literature seminars
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Seminar, Presentation, Group 1, Anders Undén, Literature seminars
12:00
09:00
19
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Seminar, Presentation, Group 5, Anders Undén, Literature seminars
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Seminar, Presentation, Group 5, Anders Undén, Literature seminars
12:00
09:00
19
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Seminar, Presentation, Group 6, Anders Undén, Literature seminars
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Seminar, Presentation, Group 6, Anders Undén, Literature seminars
12:00
09:00
3
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 2, Maxime Gestin, Lab 4: Receptor binding part 1
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 2, Maxime Gestin, Lab 4: Receptor binding part 1
10:30
09:30
9
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 3, Maxime Gestin, Lab 4: Receptor binding part 1
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 3, Maxime Gestin, Lab 4: Receptor binding part 1
10:30
09:30
15
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 5, Maxime Gestin, Lab 4: Receptor binding part 1
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 5, Maxime Gestin, Lab 4: Receptor binding part 1
10:30
09:30
3
KÖL-K434, Arrhenius KÖL, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 2, Maxime Gestin, Lab 4: Receptor binding part 1
KÖL-K434, Arrhenius KÖL, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 2, Maxime Gestin, Lab 4: Receptor binding part 1
17:00
10:30
9
KÖL-K434, Arrhenius KÖL, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 3, Maxime Gestin, Lab 4: Receptor binding part 1
KÖL-K434, Arrhenius KÖL, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 3, Maxime Gestin, Lab 4: Receptor binding part 1
17:00
10:30
15
KÖL-K434, Arrhenius KÖL, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 5, Maxime Gestin, Lab 4: Receptor binding part 1
KÖL-K434, Arrhenius KÖL, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 5, Maxime Gestin, Lab 4: Receptor binding part 1
17:00
10:30
18
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Seminar, Presentation, Group 4, Anders Undén, Literature seminars
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Seminar, Presentation, Group 4, Anders Undén, Literature seminars
15:30
13:00
18
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Seminar, Presentation, Group 3, Anders Undén, Literature seminars
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Seminar, Presentation, Group 3, Anders Undén, Literature seminars
15:30
13:00
1
KÖL-K434, Arrhenius KÖL, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 1, Daniel Patrick Twohig, Lab 1: Ca2+ flux part 1
KÖL-K434, Arrhenius KÖL, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 1, Daniel Patrick Twohig, Lab 1: Ca2+ flux part 1
17:00
13:00
2
KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 1, Daniel Patrick Twohig, Lab 1: Ca2+ flux part 2
KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 1, Daniel Patrick Twohig, Lab 1: Ca2+ flux part 2
17:00
13:00
4
C472, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 2, Maxime Gestin, Lab 4: Receptor binding part 2
C472, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 2, Maxime Gestin, Lab 4: Receptor binding part 2
17:00
13:00
4
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 6, Daniel Patrick Twohig, Lab 3: IP3 inhibition
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 6, Daniel Patrick Twohig, Lab 3: IP3 inhibition
17:00
13:00
4
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 3, Daniel Patrick Twohig, Lab 3: IP3 inhibition
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 3, Daniel Patrick Twohig, Lab 3: IP3 inhibition
17:00
13:00
8
KÖL-K434, Arrhenius KÖL, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 4, Daniel Patrick Twohig, Lab 1: Ca2+ flux part 1
KÖL-K434, Arrhenius KÖL, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 4, Daniel Patrick Twohig, Lab 1: Ca2+ flux part 1
17:00
13:00
9
KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 4, Daniel Patrick Twohig, Lab 1: Ca2+ flux part 2
KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 4, Daniel Patrick Twohig, Lab 1: Ca2+ flux part 2
17:00
13:00
10
C472, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 3, Maxime Gestin, Lab 4: Receptor binding part 2
C472, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 3, Maxime Gestin, Lab 4: Receptor binding part 2
17:00
13:00
12
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 5, Daniel Patrick Twohig, Lab 3: IP3 inhibition
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 5, Daniel Patrick Twohig, Lab 3: IP3 inhibition
17:00
13:00
12
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 4, Daniel Patrick Twohig, Lab 3: IP3 inhibition
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 4, Daniel Patrick Twohig, Lab 3: IP3 inhibition
17:00
13:00
15
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 2, Daniel Patrick Twohig, Lab 3: IP3 inhibition
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 2, Daniel Patrick Twohig, Lab 3: IP3 inhibition
17:00
13:00
15
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 1, Daniel Patrick Twohig, Lab 3: IP3 inhibition
Heilbronnsalen, C458, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 1, Daniel Patrick Twohig, Lab 3: IP3 inhibition
17:00
13:00
16
C472, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 5, Maxime Gestin, Lab 4: Receptor binding part 2
C472, Arrhenius hus C, Vån 4, KN7001, 53781,HT18,v:1836/1844,100% DAG,NML, Laboratory experiment, Group 5, Maxime Gestin, Lab 4: Receptor binding part 2
17:00
13:00
| Course code | Course name |
| KN7001 | Neurochemistry with Molecular Neurobiology |